Article

Arvidsson, Per I, Ryder, Neil, Weiss, Markus, Gross, Gerhard, Kretz, Olivier, Woessner, Ralph and Seebach, Dieter (2003) Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. Chembiochem : a European journal of chemical biology, 4 (12). pp. 1345-1347. ISSN 1439-4227

Branford, Susan, Rudzki, Zbigniew, Walsh, Sonya, Parkinson, Ian, Grigg, Andrew, Szer, Jeff, Taylor, Kerry, Herrmann, Richard, Seymour, John F, Arthur, Chris, Joske, David, Lynch, Kevin and Hughes, Tim (2003) Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood, 102 (1). pp. 276-283. ISSN 0006-4971

Galanello, Renzo, Piga, Antonio, Alberti, Daniele, Rouan, Marie-Claude, Bigler, Hilde and Séchaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo, Piga, Antonio, Alberti, Daniele Maria, Rouan, Marie-Claude, Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo, Piga, Antonio, Alberti, Daniele Maria, Rouan, Marie-Claude, Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Nisbet-Brown, Eric, Olivieri, Nancy F, Giardina, Patricia J, Grady, Robert W, Neufeld, Ellis J, Sechaud, Romain, Krebs-Brown, Axel, Anderson, Judith, Alberti, Daniele Maria, Sizer, Kurt and Nathan, David G (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet, 361 (9369). pp. 1597-1602. ISSN 0140-6736

Skerjanec, Andrej, Berenson, James, Hsu, Chyi-Hung, Major, Pierre, Miller, Wilson H, Ravera, Christina, Schran, Horst, Seaman, John and Waldmeier, Felix (2003) The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. Journal of clinical pharmacology, 43 (2). pp. 154-162. ISSN 0091-2700

Ullman, Brett R, Aja, Teresa, Deckwerth, Thomas L, Diaz, Jose-Luis, Herrmann, Julia, Kalish, Vincent J, Karanewsky, Donald S, Meduna, Steven P, Nalley, Kip, Robinson, Edward D, Roggo, Silvio, Sayers, Robert O, Schmitz, Albert, Ternansky, Robert J, Tomaselli, Kevin J and Wu, Joe C (2003) Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications. Bioorganic & Medicinal Chemistry Letters, 13 (20). pp. 3623-3626. ISSN 0960-894X

Yang, Wei, Kowal, Colleen, Sorensen, Erik and Lassota, Piotr (2003) Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery. Breast Cancer Research, 5 (Suppl ). p. 13. ISSN 1465-5411